The increased expression of CCR7 mRNA observed in AJCC stage I NSCLC patients can also be understood as a “hazard signal” resulting in the activation of inflammatory mediators, leukocyte migration, or tissue damage. Here, CCR7 is linked to non-small cell lung carcinoma.